Press Releases

Date

Title

View

21 Feb 20

4basebio AG announces allotment ratio and final number of shares for the share buy back

View View

21 Feb 20

4basebio AG: 4basebio AG announces allotment ratio and final number of shares for the share buy back

View View

18 Feb 20

Notification of the allotment ratio for the share buy back

View View

14 Feb 20

4basebio AG: 4basebio AG announces results of the public share buyback offerand final purchase price for the share buy back (news with additional features)

View View

10 Feb 20

4basebio AG: 4basebio AG decides to increase the public share buyback offer volume from 2,056,452 to 5,230,726 shares (news with additional features)

View View

21 Jan 20

4basebio AG: 4basebio AG decides to buy back 2 million treasury shares (news with additional features)

View View

21 Jan 20

4basebio AG: Expedeon AG completes change of name to 4basebio AG and of ticker symbol to 4BSB (news with additional features)

View View

02 Jan 20

Expedeon AG: Expedeon AG and Abcam plc close EUR 120 million transaction (news with additional features)

View View

19 Dec 19

Expedeon AG: Expedeon shareholders approve sale of proteomics & immunotherapy business and name change to 4basebio AG (news with additional features)

View View

21 Nov 19

Expedeon AG: Expedeon to Present at the Deutsches Eigenkapitalforum in Frankfurt / Main (news with additional features)

View View

20 Nov 19

Expedeon AG: Expedeon AG information on EUR 120 million deal with Abcam on dedicated transaction website (news with additional features)

View View

11 Nov 19

Expedeon AG: Expedeon AG signs EUR 120 million deal with Abcam for the sale of its immunology and proteomics business

View View